Full text is available at the source.
Abstract
Prescription trends for medications such as DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, and sulfonylureas were compared in patients with type 2 diabetes at high versus moderate cardiovascular risk.
- Differences in medication prescriptions may exist based on cardiovascular risk levels in patients with type 2 diabetes.
- Key sociodemographic and health characteristics were considered in the analysis of prescription trends.
- The study focuses on patients who have been treated with metformin prior to the prescription of these medications.
Simplified